Today in France, the Genetics and Cancer group recommends the analysis of the BRCA 1 and 2, PALB2, TP53, CDH1, and PTEN genes if there is a suspicion of predisposition to BC [33]. The gene discussed is PTEN; the disease is breast cancer.